Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Aida Sefidani Forough, Esther TL Lau, Kathryn J Steadman, Julie AY Cichero, Greg J Kyle, Jose Manuel Serrano Santos & Lisa M Nissen. (2018) A spoonful of sugar helps the medicine go down? A review of strategies for making pills easier to swallow. Patient Preference and Adherence 12, pages 1337-1346.
Read now
Read now
Bogumił Olczak, Grzegorz Kowalski, Wojciech Leppert, Iwona Zaporowska-Stachowiak & Katarzyna Wieczorowska-Tobis. (2017) Analgesic efficacy, adverse effects, and safety of oxycodone administered as continuous intravenous infusion in patients after total hip arthroplasty. Journal of Pain Research 10, pages 1027-1032.
Read now
Read now
Stefano de Biase, Mariarosaria Valente & Gian Luigi Gigli. (2016) Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone. Neuropsychiatric Disease and Treatment 12, pages 417-425.
Read now
Read now
Stefano de Biase, Giovanni Merlino, Mariarosaria Valente & Gian Luigi Gigli. (2016) Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects. Expert Opinion on Drug Metabolism & Toxicology 12:9, pages 1035-1045.
Read now
Read now
Vittal R. Nagar & Pravardhan Birthi. (2015) Chronic Opioid Pain Management for Chronic Kidney Disease. Journal of Pain & Palliative Care Pharmacotherapy 29:1, pages 48-50.
Read now
Read now
Krishna Devarakonda, Terri Morton, Rachel Margulis, Michael Giuliani & Thomas Barrett. (2014) Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer biphasic IR/ER combination formulation, under fed and fasted conditions. Drug Design, Development and Therapy 8, pages 1125-1134.
Read now
Read now
Stefano de Biase, Giovanni Merlino, Simone Lorenzut, Mariarosaria Valente & Gian Luigi Gigli. (2014) ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome. Expert Opinion on Drug Metabolism & Toxicology 10:10, pages 1365-1380.
Read now
Read now
Oscar A. Linares, William E. Schiesser, Annemarie Daly Linares, Darko Stefanovski & Raymond C. Boston. (2014) A Transit Compartment Model Unmasks OxyContin's Reflective Pharmacokinetics From Urine Measurements in Humans. Journal of Pain & Palliative Care Pharmacotherapy 28:2, pages 96-108.
Read now
Read now
Neil Singla, Thomas Barrett, Lisa Sisk, Kenneth Kostenbader, Jim Young & Michael Giuliani. (2014) A randomized, double-blind, placebo-controlled study of the efficacy and safety of MNK-795, a dual-layer, biphasic, immediate-release and extended-release combination analgesic for acute pain. Current Medical Research and Opinion 30:3, pages 349-359.
Read now
Read now
Oscar A. Linares, David Daly, Darko Stefanovski & Raymond C. Boston. (2013) A New Model for Using Quantitative Urine Testing as a Diagnostic Tool for Oxycodone Treatment and Compliance. Journal of Pain & Palliative Care Pharmacotherapy 27:3, pages 244-254.
Read now
Read now
Ian Power & Jon McCormack. (2007) Postoperative pain management: new, convenient analgesic therapies. Expert Opinion on Pharmacotherapy 8:4, pages 391-399.
Read now
Read now
Articles from other publishers (57)
Richard A. Slivicki, Tom Earnest, Yu‐Hsuan Chang, Rajesh Pareta, Eric Casey, Jun‐Nan Li, Jessica Tooley, Kavitha Abiraman, Yvan M. Vachez, Drew K. Wolf, Jason T. Sackey, Dhinesh Kumar Pitchai, Terrill Moore, Robert W. GereauIVIV, Bryan A. Copits, Alexxai V. Kravitz & Meaghan C. Creed. (2022) Oral oxycodone self‐administration leads to features of opioid misuse in male and female mice. Addiction Biology 28:1.
Crossref
Crossref
Allyson L. Spence, Peter S. Cogan, Bianca B. Calderon, Alan David Kaye & Kailey L. Potthoff. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
185
208
.
Atsushi Kitamura, Kei Higuchi, Toshiki Kurosawa, Takashi Okura, Yoshiyuki Kubo & Yoshiharu Deguchi. (2022) Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an <i>in Vitro</i> Human Blood–Brain Barrier Model. Biological and Pharmaceutical Bulletin 45:10, pages 1585-1589.
Crossref
Crossref
Gaotong Lin, Zhize Ye, Nanyong Gao, Xiaoqin Hu, Qihui Kong, Xiaodan Zhang & Junwei Li. (2022) The effect of anlotinib on the pharmacokinetic profile of oxycodone and the underlying mechanism. Chemico-Biological Interactions 364, pages 110044.
Crossref
Crossref
. 2022. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
511
774
.
Menglu Jiang, Jiawei Ji, Xin Li & Zhenqing Liu. (2021) Effect of intravenous oxycodone on the physiologic responses to extubation following general anesthesia. BMC Anesthesiology 21:1.
Crossref
Crossref
James D Morse, Milan Sundermann, Jacqueline A Hannam, Hannu Kokki, Merja Kokki & Brian J Anderson. (2021) Population pharmacokinetics of oxycodone: Premature neonates to adults. Pediatric Anesthesia 31:12, pages 1332-1339.
Crossref
Crossref
Moriah Carper, Katherine M. Contreras, D. Matthew Walentiny, Patrick M. Beardsley & M. Imad Damaj. (2021) Validation and characterization of oxycodone physical dependence in C57BL/6J mice. European Journal of Pharmacology 903, pages 174111.
Crossref
Crossref
Ashley Singh, Clement Zai, Ayeshah G Mohiuddin & James L Kennedy. (2020) The pharmacogenetics of opioid treatment for pain management. Journal of Psychopharmacology 34:11, pages 1200-1209.
Crossref
Crossref
Payel J. Roy, Melanie Weltman, Laura M. Dember, Jane Liebschutz & Manisha Jhamb. (2020) Pain management in patients with chronic kidney disease and end-stage kidney disease. Current Opinion in Nephrology & Hypertension 29:6, pages 671-680.
Crossref
Crossref
Sanam Dolati, Faezeh Tarighat, Fariba Pashazadeh, Kavous Shahsavarinia, Saina Gholipouri & Hassan Soleimanpour. (2020) The Role of Opioids in Pain Management in Elderly Patients with Chronic Kidney Disease: A Review Article. Anesthesiology and Pain Medicine 10:5.
Crossref
Crossref
Zhu Luo, Jia Miao, Shiqing Shu, Ying Wang, Xiaohong Zhu, Chao Hu & Yali Shen. (2019) Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain. Clinical Drug Investigation 40:2, pages 139-148.
Crossref
Crossref
Nageswara R. Pilli, Suresh Narayanasamy, Lin Xu, Ashok Chockalingam, Katherine I. Shea, Sharron Stewart, Rodney Rouse, Vikram Patel & Murali K. Matta. (2020) A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats. RSC Advances 10:2, pages 886-896.
Crossref
Crossref
Alyssa Covelli Colwill, Lisa L. Bayer, Paula Bednarek, Bharti Garg, Jeffery T. Jensen & Alison B. Edelman. (2019) Opioid Analgesia for Medical Abortion. Obstetrics & Gynecology 134:6, pages 1163-1170.
Crossref
Crossref
Christopher A. Blackwood, Michael Leary, Aaron Salisbury, Michael T. McCoy & Jean Lud Cadet. (2019) Escalated Oxycodone Self-Administration Causes Differential Striatal mRNA Expression of FGFs and IEGs Following Abstinence-Associated Incubation of Oxycodone Craving. Neuroscience 415, pages 173-183.
Crossref
Crossref
Suresh Narayanasamy, Nageswara R. Pilli, Lin Xu, Ashok Chockalingam, Katherine I. Shea, Sharron Stewart, Vikram Patel, Rodney Rouse & Murali K. Matta. (2019) An alternating polarity switching assay for quantification of oxycodone and topiramate: An application of LC-MS/MS method in support to PK/PD study in rodents. Journal of Chromatography B 1118-1119, pages 93-100.
Crossref
Crossref
Jill E. Sindt & Robert H. Jenkinson. 2019. Pharmacology and Physiology for Anesthesia. Pharmacology and Physiology for Anesthesia
354
368
.
Brian J. Anderson, Jerrold Lerman & Charles J. Coté. 2019. A Practice of Anesthesia for Infants and Children. A Practice of Anesthesia for Infants and Children
100
176.e45
.
Rei Tanaka, Hiroshi Ishikawa, Tetsu Sato, Michihiro Shino, Katsuhiro Omae, Tetsumi Sato & Iwao Osaka. (2018) Safety profile of prophylactic rescue dosing of immediate-release oral opioids in cancer patients. Journal of Pharmaceutical Health Care and Sciences 4:1.
Crossref
Crossref
Holly M. Koncicki, Mark Unruh & Jane O. Schell. (2017) Pain Management in CKD: A Guide for Nephrology Providers. American Journal of Kidney Diseases 69:3, pages 451-460.
Crossref
Crossref
Chunlu Zhang, Jiali Ding, Bin Wang & Peng Chen. (2017) A Single Intravenous Injection of Oxycodone Hydrochloride In The Treatment of Acute Post-operative Pain after Laparoscopic Rectal Tumor Resection. BIO Web of Conferences 8, pages 01055.
Crossref
Crossref
Joseph V. PergolizziJr.Jr., Francis Seow‐Choen, Steven D. Wexner, Gianpietro Zampogna, Robert B. Raffa & Robert TaylorJr.Jr.. (2015) Perspectives on Intravenous Oxycodone for Control of Postoperative Pain. Pain Practice 16:7, pages 924-934.
Crossref
Crossref
Jennifer Pruskowski & Robert M. Arnold. (2016) Opioid Pharmacokinetics #307. Journal of Palliative Medicine 19:6, pages 668-670.
Crossref
Crossref
Rasmus Olsen, David J.R. Foster, Richard N. Upton, Anne E. Olesen, Joy R. Ross, Joanne Droney, Hiroe Sato, Asbj?rn M. Drewes & Mads Kreilgaard. (2016) Modelling the PKPD of oxycodone in experimental pain ? Impact of opioid receptor polymorphisms. European Journal of Pharmaceutical Sciences 86, pages 41-49.
Crossref
Crossref
Kuan Gandelman, Michael Lamson, Candace Bramson, Kyle Matschke, Joanne Salageanu & Bimal Malhotra. (2015) Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended-release oxyco. Clinical Pharmacology in Drug Development 4:5, pages 361-369.
Crossref
Crossref
Kuan Gandelman, Michael Lamson, Joanne Salageanu, Candace Bramson, Kyle Matschke & Bimal Malhotra. (2015) Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone. Clinical Pharmacology in Drug Development 4:5, pages 370-376.
Crossref
Crossref
Holly M. Koncicki, Frank Brennan, Katie Vinen & Sara N. Davison. (2015) An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms. Seminars in Dialysis 28:4, pages 384-391.
Crossref
Crossref
Johan Ræder & Harald Breivik. (2015) Oral immediate and prolonged release oxycodone for safe and effective patient controlled analgesia after surgery Can opioid for acute postoperative pain be improved by adding a peripheral opioid antagonist?. Scandinavian Journal of Pain 7:1, pages 25-27.
Crossref
Crossref
Oscar A. Linares, William E. Schiesser & Annemarie Daly. (2015) Organ-specific Microcirculatory Mass Transport of Oxycodone in Humans. The Clinical Journal of Pain 31:3, pages 206-213.
Crossref
Crossref
Marta Torrens, Francina Fonseca, Liliana Galindo & Magi Farré. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
467
500
.
Holly M. Koncicki. 2015. Pain Management and Palliative Care. Pain Management and Palliative Care
213
226
.
Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine & Robert B. Raffa. (2014) Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics. Journal of Cancer Research Updates 3:4.
Crossref
Crossref
W. Syrmis, P. Good, J. Wootton & G. Spurling. (2014) Opioid conversion ratios used in palliative care: is there an Australian consensus?. Internal Medicine Journal 44:5, pages 483-489.
Crossref
Crossref
Stephen C. Harris, Peter J. Perrino, Ira Smith, Megan J. Shram, Salvatore V. Colucci, Cynthia Bartlett & Edward M. Sellers. (2013) Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse‐deterrent controlled‐release tablets in recreational opioid users. The Journal of Clinical Pharmacology 54:4, pages 468-477.
Crossref
Crossref
Celeste B. Burness & Gillian M. Keating. (2014) Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation. Drugs 74:3, pages 353-375.
Crossref
Crossref
Moutaz Burwaiss & Dee Comerford. (2013) Techniques of opioid administration. Anaesthesia & Intensive Care Medicine 14:11, pages 491-495.
Crossref
Crossref
Peter J. Perrino, Salvatore V. Colucci, Glen Apseloff & Stephen C. Harris. (2013) Pharmacokinetics, Tolerability, and Safety of Intranasal Administration of Reformulated OxyContin® Tablets Compared with Original OxyContin® Tablets in Healthy Adults. Clinical Drug Investigation 33:6, pages 441-449.
Crossref
Crossref
Karin C. S?derberg L?fdal, Marine L. Andersson & Lars L. Gustafsson. (2013) Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications. Drugs 73:6, pages 533-543.
Crossref
Crossref
Takafumi Naito, Masaki Tashiro, Keisuke Yamamoto, Kazunori Ohnishi, Yoshiyuki Kagawa & Junichi Kawakami. (2012) Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients. European Journal of Clinical Pharmacology 68:10, pages 1411-1418.
Crossref
Crossref
Marija Bosilkovska, Bernhard Walder, Marie Besson, Youssef Daali & Jules Desmeules. (2012) Analgesics in Patients with Hepatic Impairment. Drugs 72:12, pages 1645-1669.
Crossref
Crossref
Eef Hoeben, Johan W. Smit, David Upmalis, Sarah Rusch, Klaus Schaffler, Peter Reitmeir & Bernhard Mangold. (2012) Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects. Pain 153:8, pages 1648-1656.
Crossref
Crossref
Urspeter Masche. (2012) Oxycodon/Naloxon. pharma-kritik 34:2.
Crossref
Crossref
Janet Hardy, Ross Norris, Helen Anderson, Angela O?Shea & Bruce Charles. (2011) Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?. Supportive Care in Cancer 20:4, pages 767-772.
Crossref
Crossref
Takafumi Naito, Yoshiaki Takashina, Keisuke Yamamoto, Masaki Tashiro, Kazunori Ohnishi, Yoshiyuki Kagawa & Junichi Kawakami. (2011) CYP3A5*3 Affects Plasma Disposition of Noroxycodone and Dose Escalation in Cancer Patients Receiving Oxycodone. The Journal of Clinical Pharmacology 51:11, pages 1529-1538.
Crossref
Crossref
Dee Comerford. (2011) Techniques of opioid administration. Anaesthesia & Intensive Care Medicine 12:1, pages 16-20.
Crossref
Crossref
Jesús González-Barboteo, Jordi Trelis-Navarro, Albert Tuca-Rodríguez & Xavier Gómez-Batiste. (2010) Rotación de opioides: una alternativa en el tratamiento del dolor refractario en pacientes con cáncer. Medicina Clínica 135:13, pages 617-622.
Crossref
Crossref
Howard Smith & Patricia Bruckenthal. (2010) Implications of Opioid Analgesia for Medically Complicated Patients. Drugs & Aging 27:5, pages 417-433.
Crossref
Crossref
Sarah J Mitchell, Sarah N Hilmer & Andrew J McLachlan. (2009) Clinical pharmacology of analgesics in old age and frailty. Reviews in Clinical Gerontology 19:2, pages 103-118.
Crossref
Crossref
Anna Axelin, Sanna Salanterä, Jarkko Kirjavainen & Liisa Lehtonen. (2009) Oral Glucose and Parental Holding Preferable to Opioid in Pain Management in Preterm Infants. The Clinical Journal of Pain 25:2, pages 138-145.
Crossref
Crossref
A. PESONEN, R. SUOJARANTA-YLINEN, E. HAMMAR?N, P. TARKKILA, T. SEPP?L?P. H. ROSENBERG. (2009) Comparison of effects and plasma concentrations of opioids between elderly and middle-aged patients after cardiac surgery. Acta Anaesthesiologica Scandinavica 53:1, pages 101-108.
Crossref
Crossref
Charles J. Coté, Jerrold Lerman, Robert M. Ward, Ralph A. Lugo & Nishan Goudsouzian. 2009. A Practice of Anesthesia for Infants and Children. A Practice of Anesthesia for Infants and Children
89
146
.
Vincent Ho, Maxwell Stewart & Peter Boyd. (2008) Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report. Journal of Medical Case Reports 2:1.
Crossref
Crossref
Dee Comerford. (2008) Techniques of opioid administration. Anaesthesia & Intensive Care Medicine 9:1, pages 21-26.
Crossref
Crossref
Stefan J. Friedrichsdorf & Tammy I. Kang. (2007) The Management of Pain in Children with Life-limiting Illnesses. Pediatric Clinics of North America 54:5, pages 645-672.
Crossref
Crossref
Rolf Terlinden, Joachim Ossig, Frank Fliegert, Claudia Lange & Karin Göhler. (2007) Absorption, metabolism, and excretion of14C-labeled Tapentadol HCl in healthy male subjects. European Journal of Drug Metabolism and Pharmacokinetics 32:3, pages 163-169.
Crossref
Crossref
Renée McCulloch & John J. Collins. (2006) Pain in Children Who Have Life-Limiting Conditions. Child and Adolescent Psychiatric Clinics of North America 15:3, pages 657-682.
Crossref
Crossref
Hong-Kee Lee, Lionel D. Lewis, Gregory J. Tsongalis, Matthew McMullin, Bernard C. Schur, Steven H. Wong & Kiang-Teck J. Yeo. (2006) Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism. Clinica Chimica Acta 367:1-2, pages 196-200.
Crossref
Crossref